NYC RxStat: A Collaborative Approach to Surveillance of Prescription Drug Misuse and Associated Consequences
|
|
- Bruce Robertson
- 8 years ago
- Views:
Transcription
1 NYC RxStat: A Collaborative Approach to Surveillance of Prescription Drug Misuse and Associated Consequences National Governor s Association Institute for Governors Criminal Justice Policy Advisors Washington, DC May 1,
2 Introduction Chauncey Parker Director of New York/New Jersey High Intensity Drug Trafficking Area (HIDTA) Steven Newmark Sr. Policy Advisor & Counsel to the Deputy Mayor for Health and Human Services, New York City Office of the Mayor Denise Paone Director of Research & Surveillance, Bureau of Alcohol & Drug Use Prevention, Care & Treatment, New York City Department of Health & Mental Hygiene 2
3 Outline NYC RxStat Overview Public Health Data Sources Data Driven Opioid Policies and Strategies in New York City 3
4 Steven Newmark, JD/MPA, Sr. Policy Advisor & Counsel to the Deputy Mayor for Health and Human Services New York City Office of the Mayor RXSTAT OVERVIEW 4
5 Opioid Analgesics Are a Public Health Crisis in New York City 5 *Paone D, Bradley O Brien D, Shah S, Heller D. Opioid analgesics in New York City: misuse, morbidity and mortality update. Epi Data Brief. April Available at
6 RxStat: Central Focus and Unifying Goal Reduce Overdose Deaths 6
7 RxStat: Four Core Principles Timely, accurate analysis of drug misuse indicators from multiple sources (e.g., mortality, EDs, PMP, drug treatment, law enforcement, etc.) Develop strategies based on analysis of existing and newly available data Rapid deployment of public health and public safety resources to high priority areas Rigorous follow-up to ensure strategies are effective 7
8 RxStat Public health & public safety collaboration Housed at NYC Department of Health & Mental Hygiene (DOHMH) leverages expertise and infrastructure Real-time (enhanced) surveillance Participants and stakeholders at city, state, and federal organizations Monthly RxStat Data Meetings 8
9 Layering and Reporting Data Reduce Overdose Deaths 9
10 Data Sources Price/Purity Qualitative Research Mortality Medicaid Fraud Data PMP Data Drug Prosecutions Reduce Overdose Deaths Hospitalizations Syndromic Poison Control Pharmacy Crime 10 DEA ARCOS Treatment Admissions Jail Data
11 Denise Paone, EdD, Director of Research & Surveillance Bureau of Alcohol & Drug Use Prevention, Care & Treatment New York City Department of Health and Mental Hygiene PUBLIC HEALTH DATA SOURCES 11
12 Number 900 Opioids Were Involved In 73% of Overdose Deaths in NYC Total Opioids Heroin NOTE: Drugs not mutually exclusive Opioid Analgesics Year of Death 12 Source: New York City Office of the Chief Medical Examiner & New York City Department of Health and Mental Hygiene
13 Number Age-adjusted rate per 100,000 Opioid Analgesic Overdose Deaths Increased 233% from 2000 to 2012, NYC Number of unintentional opioid analgesic poisoning deaths Age-adjusted rate per 100, Source: New York City Office of the Chief Medical Examiner & New York City Department of Health and Mental Hygiene
14 Age-Adjusted Rate per 100,000 Staten Island residents had the highest rate of opioid-analgesic overdose death Staten Island Manhattan Bronx Brooklyn Queens Source: New York City Office of the Chief Medical Examiner & New York City Department of Health and Mental Hygiene
15 Number Age-adjusted rate per 100,000 Heroin Overdose Deaths Increased 84% from 2010 to 2012, NYC Number of unintentional heroin poisoning deaths Age-adjusted rate per 100, Source: New York City Office of the Chief Medical Examiner & New York City Department of Health and Mental Hygiene
16 Age-Adjusted Rate per 100,000 Staten Island residents had the highest rate of heroin overdose death Bronx Staten Island Manhattan Brooklyn Queens Source: New York City Office of the Chief Medical Examiner & New York City Department of Health and Mental Hygiene
17 PRESCRIPTION MONITORING PROGRAM 17
18 Number of Prescriptions 2,500,000 Opioid analgesic (OA) prescriptions NYC, Opioid analgesic prescriptions 2,000,000 Note: Schedule II opioid analgesics 1,500,000 1,000,000 Oxycodone Hydrocodone 500, Source: New York State Department of Health, Bureau of Narcotic Enforcement, Prescription Drug Monitoring Program, Year
19 Age-adjusted rate of prescriptions filled per 1,000 residents Staten Islanders filled OA prescriptions 500 at higher rates in Opioid Analgesics Oxycodone Hydrocodone Note: Schedule II opioid analgesics NYC Bronx Brooklyn Manhattan Queens Staten Island Rates are adjusted to 2000 US Standard population Source: New York State Department of Health, Bureau of Narcotic Enforcement, Prescription Drug Monitoring Program, 2012 Borough of Residence
20 Median Supply, Days OA prescriptions filled by Staten Islanders have longer median day supply 30 Note: Schedule II opioid analgesics Median day supply is calculated from day supply of each prescription filled in the year NYC Bronx Brooklyn Manhattan Queens Staten Island Source: New York State Department of Health, Bureau of Narcotic Enforcement, Prescription Drug Monitoring Program, 2012 Borough of Residence
21 Age-adjusted rate of prescriptions filled per 1,000 residents OA prescriptions filled by Staten Islanders are more frequently high dose (>100 MED) Note: Schedule II opioid analgesics High dose is any opioid analgesic prescription with a calculated morphine equivalent dose (MED) greater than 100. Among patients receiving opioid prescriptions, overdose rates increase with increasing doses of prescribed opioids NYC Bronx Brooklyn Manhattan Queens Staten Island Rates are adjusted to 2000 US Standard population Source: New York State Department of Health, Bureau of Narcotic Enforcement, Prescription Drug Monitoring Program, Borough of Residence
22 Concerns about initiation of heroin associated with opioid analgesic use NSDUH data show: Recent (12-months preceding interview) rate for new heroin initiates was 19 times higher among those who reported nonmedical opioid analgesic use than among those who did not use nonmedical opioids Four out of five heroin initiates (79.5%) had used nonmedical opioid analgesics whereas only 1% of recent opioid analgesic initiates had used heroin Source: CBHSQ Data Review, August
23 Denise Paone, EdD, Director of Research & Surveillance Bureau of Alcohol & Drug Use Prevention, Care & Treatment New York City Department of Health and Mental Hygiene USING DATA TO INFORM OPIOID POLICIES AND STRATEGIES IN NEW YORK CITY 23
24 Neighborhoods with high rates of OA prescriptions have high rates of unintentional (overdose) deaths involving opioid analgesics OA PRESCRIPTION RATES OA MORTALITY RATES *Paone D, Bradley O Brien D, Shah S, Heller D. Opioid analgesics in New York City: misuse, morbidity and mortality update. Epi Data Brief. April Available at
25 Opioid Prescribing Guidelines Less often: avoid prescribing opioids for chronic non-cancer, non-end-of-life pain e.g., low back pain, arthritis, headache, fibromyalgia Shorter duration: when opioids are warranted for acute pain, 3-day supply usually sufficient Lower doses: if dosing reaches 100 Morphine Milligram Equivalents (MME), reassess and reconsider other approaches to pain management Avoid whenever possible prescribing opioids in patients taking benzodiazepines Citation: Paone D, Dowell D, Heller D. Preventing misuse of prescription opioid drugs. City Health Information. 2011; 30(4): New York City Opioid Treatment Guidelines, Clinical Advisors: Nancy Chang, MD; Marc N. Gourevitch, MD, MPH; Mark P. Jarrett, MD, MBA; Andrew Kolodny, MD; Lewis Nelson, MD; Russell K. Portenoy, MD; Jack Resnick, MD; Stephen Ross, MD; Joanna L. Starrels, MD, MS; David L. Stevens, MD; Anne Marie Stilwell, MD; Theodore Strange; MD, FACP; Homer Venters, MD, MS
26 Emergency Department Guidelines Released January, 2013 Adopted by 38 NYC emergency departments 26 New York City Emergency Department Discharge Opioid Prescribing Guidelines Clinical Advisory Group: Jason Chu, MD, Brenna Farmer, MD, Beth Y. Ginsburg, MD, Stephanie H. Hernandez, MD, James F. Kenny, MD, MBA, FACEP, Nima Majlesi, DO, Ruben Olmedo, MD, Dean Olsen, DO, James G. Ryan, MD, Bonnie Simmons, DO, Mark Su, MD, Michael Touger, MD, Sage W. Wiener, MD.
27 Staten Island Public Health Detailing Campaign 1-on-1 detailing visits from Health Department representatives Deliver key prescribing recommendations, clinical tools, patient education materials ~1,000 Staten Island physicians, nurse practitioners, physicians assistants June August
28 28
29 Morphine Milligram Equivalent (MME) Calculator A tool to calculate total MME per day Gives alert for dosages >100 MME Quick and easy to use Web-based application Search for NYC MME Calculator Smartphone app 29
30 Media Campaigns Campaign One: Goal: Increase awareness of risk of opioid analgesic overdose Ran twice (2012, 2013) Campaign Two: Goal: Reduce stigma and raise awareness of opioid analgesic misuse 2 testimonials Mom lost son to opioid analgesic overdose NYC resident in recovery Ran 2013 and
31 Available at:
32 Overdose (OD) Prevention: Naloxone 32
33 In New York State, trained laypersons can legally administer naloxone for OD prevention Per NYS Public Health Law Opioid Overdose Prevention Program Effective April 1, 2006 Laypersons can become Trained Overdose Responders Trained Overdose Responders can legally carry and use naloxone 33
34 Intranasal Naloxone Distribution in NYC Since 2010 Drug Treatment Programs 13% Syringe Exchange Programs 73% Other (e.g., shelters, hospitals) 14% >25,000 kits distributed >200 reversals reported (underreporting) 34
35 NYC Department of Homeless Services (DHS) More than half DHS Peace Officers are trained and carry naloxone in all city shelters 35
36 NYPD Naloxone Project All NYPD officers in the 120 precinct on Staten Island (approximately 180) have been trained to carry and dispense naloxone Reported reversals 36
37 New York State Good Samaritan Law 37
38 Summary RxStat is a collaboration between NYC public health and public safety toward one unifying goal: Reduce overdose deaths in NYC Opioid overdose deaths are preventable Multi-pronged data driven approaches are needed 38
Data-Driven Multi-Disciplinary Approaches to Reducing Rx Abuse, BJA Award FY 2014
Data-Driven Multi-Disciplinary Approaches to Reducing Rx Abuse, BJA Award FY 2014 Denise Paone and Alexandra Harocopos Bureau of Alcohol & Drug Use Prevention, Care & Treatment New York City Department
More informationMayor s Task Force On Prescription Painkiller Abuse
Mayor s Task Force On Prescription Painkiller Abuse Interim Report January 2013 BACKGROUND In response to a growing epidemic, in late 2011 Mayor Bloomberg created the multi-agency Task Force on Prescription
More informationTestimony of The New York City Department of Health and Mental Hygiene. before the
Testimony of The New York City Department of Health and Mental Hygiene before the New York City State Assembly Committee on Alcoholism and Drug Abuse on Programs and Services for the Treatment of Opioid
More informationTestimony of. Daliah Heller, PhD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment
Testimony of Daliah Heller, PhD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment New York City Department of Health and Mental Hygiene before the New York City
More informationNaloxone Distribution for Opioid Overdose Prevention
Naloxone Distribution for Opioid Overdose Prevention Caleb Banta-Green PhD, MPH, MSW Alcohol and Drug Abuse Institute, University of Washington Alan Melnick, MD, MPH Clark County Public Health Chris Humberson,
More informationCDC s Prevention Efforts to Address Prescription Opioid Epidemic
CDC s Prevention Efforts to Address Prescription Opioid Epidemic Jan Losby, PhD, MSW Lead, Prescription Drug Overdose Health Systems and State Support Team Division of Unintentional Injury Prevention NASBO
More informationTraci C. Green, PhD, MSc Jody Rich, MD, MPH
Traci C. Green, PhD, MSc Jody Rich, MD, MPH Strategic Plan highlights Comments & Responses from public, stakeholders Input and discussion Next steps Death rate for U.S. non-hispanic whites (USW), U.S.
More informationAGENDA. 2014 Institute for Governors Criminal Justice Policy Advisors
AGENDA 2014 Institute for Governors Criminal Justice Policy Advisors Bureau of Justice Assistance Office of Justice Programs 810 Seventh Street NW Washington, DC 20531 May 1-2, 2014 Hosted by: In partnership
More informationUNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths
UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths Joanna G Katzman, M.D., M.S.P.H Director, UNM Pain Center Associate Professor,
More informationA Local Multifaceted, Multidisciplinary Approach to Opiate Overdose & Death
A Local Multifaceted, Multidisciplinary Approach to Opiate Overdose & Death 2013 WPHA-WALHDAB Annual Conference Wednesday, May 22: 2:00-2:35 pm Lisa Bullard-Cawthorne, MS, MPH OPIATE PREVALENCE IN DANE
More informationPrescription Drugs: Impacts of Misuse and Accidental Overdose in Mississippi. Signe Shackelford, MPH Policy Analyst November 19, 2013
Prescription Drugs: Impacts of Misuse and Accidental Overdose in Mississippi Signe Shackelford, MPH Policy Analyst November 19, 2013 Center for Mississippi Health Policy Independent, non-profit organization
More informationThe Opioid Addiction Epidemic: How marketing and regulatory failure led to a public health crisis
The Opioid Addiction Epidemic: How marketing and regulatory failure led to a public health crisis Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians
More informationCelebrating a Year of Expanded Naloxone Access and Overdose Education within Cuyahoga County
Cuyahoga County March 2014, Issue 1 Celebrating a Year of Expanded Naloxone Access and Overdose Education within Cuyahoga County According to the Ohio Department of Health (ODH), between 1999 and 2011,
More informationMassachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District
Massachusetts Substance Abuse Policy and Practices Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District November 2014 Substance Abuse and Addiction National and State opioid abuse
More informationTestimony. Thomas A. Farley, MD, MPH Commissioner. and. Adam Karpati, MD, MPH Executive Deputy Commissioner, Division of Mental Hygiene
Testimony of Thomas A. Farley, MD, MPH Commissioner and Adam Karpati, MD, MPH Executive Deputy Commissioner, Division of Mental Hygiene New York City Department of Health and Mental Hygiene before the
More informationPrescription Opioid Overdose & Misuse in Oregon
Prescription Opioid Overdose & Misuse in Oregon Mel Kohn, MD MPH Public Health Director and State Public Health Officer Oregon Health Authority Oregon In-State Policy Workshop NGA Policy Academy: Reducing
More informationPrescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth
Prescription drug abuse trends Minnesota s Prescription Monitoring Program Carol Falkowski Drug Abuse Dialogues www.drugabusedialogues.com Barbara Carter, Manager MN Board of Pharmacy www.pmp.pharmacy.state.mn.us
More informationINFO Brief. Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State
ADAI-IB 23-3 INFO Brief Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State O ctober 23 Caleb Banta-Green (Alcohol and Drug Abuse Institute, University of Washington),
More informationThe Prescription Drug Abuse and Heroin Crisis: New York s Response
The Prescription Drug Abuse and Heroin Crisis: New York s Response Joshua S. Vinciguerra, Director Bureau of Narcotic Enforcement October 28, 2015 October 28, 2015 2 The Connection States with more opioid
More informationJAN 2 7 2016. poisonings, commonly referred to as drug overdoses, are one of. the leading causes of injury-related mortality in Hawaii.
THE SENATE TWENTY-EIGHTH LEGISLATURE, 0 STATE OF HAWAII JAN 0 A BILL FOR AN ACT S.B. NO. % RELATING TO DRUG OVERDOSE PREVENTION BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII: 0 SECTION. The legislature
More informationOpioids and the Injured Worker Tools for Successful Outcomes
Opioids and the Injured Worker Tools for Successful Outcomes Tim Pokorney, RPh Director, Clinical Express Scripts Workers' Compensation Division Goals and Objectives Alarming statistics for narcotic utilization,
More informationWashington State Interagency Opioid Working Plan
Washington State Interagency Opioid Working Plan INTRODUCTION January 2016 Washington State is currently experiencing an opioid abuse and overdose crisis involving prescription opioids and heroin. Approximately
More informationPart 1: Opioids and Overdose in the U.S. and New Mexico. Training: New Mexico Pharmacist Prescriptive Authority for Naloxone Protocol 7/15/2015
Training: New Mexico Pharmacist Prescriptive Authority for Naloxone Protocol New Mexico Pharmacists Association & Project ECHO 2014 This training fulfills the educational requirement for pharmacists in
More informationMEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS
MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS David Gaugh, R.Ph. Senior Vice President for Sciences and Regulatory
More information2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov
OHIO AUTOMATED RX REPORTING SYSTEM 2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov OHIO AUTOMATED RX REPORTING SYSTEM What is OARRS? To address the growing misuse and diversion
More informationImplementing Prescribing Guidelines in the Emergency Department. April 16, 2013
Implementing Prescribing Guidelines in the Emergency Department April 16, 2013 Housekeeping Note: Today s presentation is being recorded and will be provided within 48 hours. Two ways to ask questions
More informationPrescription Drug Abuse and Overdose: Public Health Perspective
Prescription Drug Abuse and Overdose: Public Health Perspective [Residency educators may use the following slides for their own teaching purposes.] CDC s Primary Care and Public Health Initiative October
More informationWHAT WE KNOW. Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE
Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE WHAT WE KNOW The misuse and abuse of prescription drugs has become a leading cause of harm among New Hampshire adults,
More informationThe Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians for Responsible Opioid Prescribing
More informationArkansas Emergency Department Opioid Prescribing Guidelines
Arkansas Emergency Department Opioid Prescribing Guidelines 1. One medical provider should provide all opioids to treat a patient s chronic pain. 2. The administration of intravenous and intramuscular
More informationPalmer MacKie, MD MS Director, Integrative Pain Program, Eskenazi Department of Medicine, IUSOM
Palmer MacKie, MD MS Director, Integrative Pain Program, Eskenazi Department of Medicine, IUSOM Attorney General s Prescription Drug Abuse Task Force Member AIT Laboratories Advisory Board In 2009, 44%
More informationDEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services. NEW products from the Medicare Learning Network (MLN)
Medicare Advantage Outreach and Education Bulletin Anthem Blue Cross Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain management. The Centers
More informationPRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE
PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE May 19, 2012 National Association Boards of Pharmacy Annual Meeting Gil Kerlikowske, Director White House Office of National Drug Control Policy ONDCP
More informationPresenter Discloser. Mapping an Opioid Overdose Prevention Program: From Jail to Community 10/28/2015 CORRECTIONAL HEALTH SERVICES
Mapping an Opioid Overdose Prevention Program: From Jail to Community Anne Siegler, Alison O. Jordan,Allison Dansby, Randi Sinnreich, Quintin Maidment and Zachary Rosner NYC HHC Correctional Health Services
More informationNaloxone: Overview, Criminal Justice and other Special Settings
Naloxone: Overview, Criminal Justice and other Special Settings Ingrid Binswanger, MD, MPH, MS Division of General Internal Medicine Affiliated Member, Division of Substance Dependence University of Colorado
More informationHeroin in Snohomish County: Mortality and Treatment Trends
Heroin in Snohomish County: Mortality and Treatment Trends January 2015 This page left intentionally blank. Table of Contents Introduction and Acknowledgments 1 Executive Summary 2 Mortality Overdose Mortality
More informationTestimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013
Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013 Chairman Lee, members of the Senate Human Services Committee,
More informationPresentation by: Commissioner E. Douglas Varney
Presentation by: Commissioner E. Douglas Varney Prescription Drug Abuse Affects Everyone Families as a whole Women Children The abuse of prescription drugs, particularly opioids, is costly not only for
More informationOVERDOSE EDUCATION & NALOXONE DISTRIBUTION (OEND) IN MICHIGAN P A M E L A L Y N C H, L L M S W, C A A D C W H O S O E V E R C O L L A B O R A T I V E
OVERDOSE EDUCATION & NALOXONE DISTRIBUTION (OEND) IN MICHIGAN P A M E L A L Y N C H, L L M S W, C A A D C W H O S O E V E R C O L L A B O R A T I V E Sales of opioids: Michigan is above the median in
More informationPopulations at risk for opioid overdose
Populations at risk for opioid overdose Len Paulozzi, MD, MPH Division of Unintentional Injury Prevention National Center for Injury Prevention and Control Centers for Disease Control and Prevention April
More informationPrescription Drug Monitoring Program Center of Excellence at Brandeis
Prescription Drug Monitoring Program Center of Excellence at Brandeis Notes from the Field NF 4.1 Using PDMPs to Improve Medical Care: Washington State s Data Sharing Initiative with Medicaid and Workers
More informationSTATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council
STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council PRIORITY AREA: PRESCRIBERS Recommendation: The Council recommends that
More informationJane Maxwell, UT Addiction Research Institute, 512 232-0610. Prescription Pain Medications and Heroin: A Changing Picture
Prescription Pain Medications and : A Changing Picture Jane Maxwell, Ph.D. Center for Social Work Research The University of Texas at Austin Disclosure to Participants Commercial Support: This educational
More informationDrug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008
PRESCRITPION DRUG ABUSE: AN EPIDEMIC What is Addiction? By: Lon R. Hays, M.D., M.B.A. Professor and Chairman Department of Psychiatry University of Kentucky Healthcare Addiction is a primary, chronic disease
More informationOpioids for Pain Treatment. Opioids for Chronic Pain and Addiction Treatment. Outline for Today. Opioids for pain treatment
Opioids for Chronic Pain and Addiction Treatment Joseph Merrill M.D., M.P.H. University of Washington February 24, 2012 Outline for Today Opioids for pain treatment Trends Problems High dose prescribing
More informationReforming the Response To Substance Use: A Drug Policy for the 21 st Century
Reforming the Response To Substance Use: A Drug Policy for the 21 st Century 2015 NASADAD MEETING Charleston, SC June 2, 2015 David Mineta, Deputy Director Office of Demand Reduction Office of National
More informationPRESCRIPTION PAINKILLER OVERDOSES
IMPACT{ POLICY PRESCRIPTION PAINKILLER OVERDOSES National Center for Injury Prevention and Control Division of Unintentional Injury Prevention What s the Issue? In a period of nine months, a tiny Kentucky
More information2013 OHIO DRUG OVERDOSE DATA: GENERAL FINDINGS 1
Number of Deaths Rate per 100,000 persons 2013 OHIO DRUG OVERDOSE DATA: GENERAL FINDINGS 1 Drug overdose deaths continue to be a public health crisis in Ohio with a 413 percent increase in the number of
More informationOpiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio
Governor s Cabinet Opiate Action Team Promoting Wellness and Recovery John R. Kasich, Governor Tracy J. Plouck, Director Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio November 14,
More informationStrong States, Strong Nation POLICY OPTIONS TO DECREASE RISKS FROM THE USE OF METHADONE AS A PAIN RELIEVER
Strong States, Strong Nation POLICY OPTIONS TO DECREASE RISKS FROM THE USE OF METHADONE AS A PAIN RELIEVER November 17, 2015 Today s Speakers Karmen Hanson, Program Manager, NCSL Cynthia Reilly, Director,
More informationGovernor s Task Force on Mental Health and Substance Use. www.ncdhhs.gov/mhsu
Governor s Task Force on Mental Health and Substance Use www.ncdhhs.gov/mhsu Problem Statement 97 Painkiller prescriptions per 100 North Carolinians Number of deaths by drug overdose in North Carolina
More informationPrescriber Behavior, Pain Treatment and Addiction Treatment
Prescriber Behavior, Pain Treatment and Addiction Treatment Mary Fleming, M.S. Director, Office of Policy, Planning, and Innovation Substance Abuse and Mental Health Services Administration NGA Policy
More informationKing County Drug Trends 2015
Brad Finegood, MA, LMHC Assistant Division Director, Acting RSN Administrator Prevention and Treatment Coordinator King County Behavioral Health and Recovery Division Caleb Banta-Green PhD, MPH, MSW Senior
More informationDeath in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery
Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Marvin D. Seppala, MD Chief Medical Officer Hazelden Betty Ford Foundation This product is supported by
More informationAmerican Indian Health Commission for Washington State October 1, 2015
American Indian Health Commission for Washington State October 1, 2015 States with more opioid pain reliever sales tend to have more drug overdose deaths Death rate, 2011, National Vital Statistics System.
More informationPennsylvania s ABC-MAP Program
Pennsylvania s ABC-MAP Program Recommendations on Best Practices ABC-MAP Governance Board Meeting May 20, 2015 Brandon C. Maughan, MD, MHS Marcus A. Bachhuber, MD University of Pennsylvania Philadelphia
More informationPrescription Opioid Use and Opioid-Related Overdose Death TN, 2009 2010
Prescription Opioid Use and Opioid-Related Overdose Death TN, 2009 2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence Service Officer Tennessee Department of
More informationOrange County Heroin Task Force Recommendations
Orange County Heroin Task Force Recommendations Law Enforcement Subcommittee 1) Continue Joint Enforcement Details with the Orange County Sheriff s Office, the Orlando Police Department and state and federal
More informationPresentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas
Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas David Lakey, MD Commissioner, Department of State Health Services Lauren Lacefield Lewis Assistant Commissioner,
More informationPrescription Drug Abuse in the US
TM The other epidemic: Prescription Drug Abuse in the US Ten prevention ideas from the states Len Paulozzi, MD, MPH National Center for Injury Prevention and Control Presented at the National Conference
More informationDrug Abuse Trends in the Seattle/King County Area: 2013
Drug Abuse Trends in the Seattle/King County Area: 2013 Caleb Banta-Green 1, T. Ron Jackson 2, Steve Freng 3, Michael Hanrahan 4, Cynthia Graff 5, John Ohta 6, Mary Taylor 7, Richard Harruff 8, Robyn Smith
More informationTRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013
2013 to 2002 States: United the in Use Heroin in Trends National Survey on Drug Use and Health Short Report April 23, 2015 TRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013 AUTHORS Rachel N. Lipari,
More informationCDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis Grant Baldwin, PhD, MPH February 2, 2016 National Center for Injury Prevention and Control Division of Unintentional Injury
More informationPrescription Drug Monitoring Programs
Prescription Drug Monitoring Programs Montana State Fund 13 th Annual Medical Conference November 1, 2013 Peter Kreiner, Ph.D. PDMP Center of Excellence at Brandeis University Primary non-heroin opiates/synthetics
More informationPrescription Drug Abuse and Pain Management Clinics 2015 Report to the 109 th Tennessee General Assembly
Prescription Drug Abuse and Pain Management Clinics 2015 Report to the 109 th Tennessee General Assembly Andrea Huddleston, Chief Deputy General Counsel Tennessee Department of Health Office of General
More informationDrug Abuse Trends in the Seattle-King County Area: 2014
Drug Abuse Trends in the Seattle-King County Area: 2014 June 12, 2015 Caleb Banta-Green 1, T. Ron Jackson 2, Steve Freng 3, Michael Hanrahan 4, Cynthia Graff 5, John Ohta 6, Mary Taylor 7, Richard Harruff
More informationPreventing Opioid Abuse and Consequences, Including Heroin, in New England: An Opportunity for Cross-State Collaboration
Preventing Opioid Abuse and Consequences, Including Heroin, in New England: An Opportunity for Cross-State Collaboration November 17, 2015 SAMHSA s Center for the Application of Prevention Technologies
More informationTrends of Opioid Misuse and Diversion: Lessons from the United States
Trends of Opioid Misuse and Diversion: Lessons from the United States 31 October 2012 Richard C. Dart, MD, PhD Director Rocky Mountain Poison and Drug Center Professor - University of Colorado, Department
More informationFirst on the Scene: People Who Use Drugs, their Families and their Friends. Sharon Stancliff, MD, FAAFP Harm Reduction Coalition New York, NY
First on the Scene: People Who Use Drugs, their Families and their Friends Sharon Stancliff, MD, FAAFP Harm Reduction Coalition New York, NY A brief history with a common theme Chicago 1996: Chicago Recovery
More informationFlagship Priority: Mental Health and Substance Abuse
10 Colorado s winnable battles Flagship Priority: Mental Health and Substance Abuse ELEVATING HEALTH AND ENVIRONMENT Mental and emotional well-being is essential to shaping a state of health for Coloradans.
More informationExpanding access to treatment for opiate addiction: Successes and Barriers
Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise Lodge Addiction Treatment Hospital, NM Department of Health; and UNM Project ECHO
More informationOPIOID OVERDOSE RESPONSE AND NALOXONE ADMINISTRATION
1.0 Purpose OPIOID OVERDOSE RESPONSE AND NALOXONE ADMINISTRATION This is a DESC internal operational policy and procedure document [effective date: 06/26/2015] Greg Jensen, Director of Administrative Services
More informationMaximizing Use of Prescription Drug Monitoring Programs
Maximizing Use of Prescription Drug Monitoring Programs Christopher M..Jones, PharmD, MPH Division of Unintentional Injury Prevention National Center for Injury Prevention and Control Centers for Disease
More informationRESPONSE TO THE MASSACHUSETTS OPIOID PRESCRIPTION DRUG EPIDEMIC
RESPONSE TO THE MASSACHUSETTS OPIOID PRESCRIPTION DRUG EPIDEMIC 2014 Report of Best Practices Joint Policy Working Group With the goal of reducing diversion, abuse and addiction and protecting access for
More information3/27/2012. Supply and Demand: The Substance Abuse/Misuse Market Triangle
Substance Abuse and Misuse: A Tragic Market That Can Be Curtailed Tennessee Department of Health Protect, promote, and improve the health and prosperity of persons in the State of Tennessee. John J. Dreyzehner,
More informationThe Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section
The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section TITLE I: PREVENTION SUBTITLE A- PRESCRIBER EDUCATION PRACTITIONER EDUCATION This subtitle requires practitioners who
More informationNational Perspectives in Medication Assisted Treatment
National Perspectives in Medication Assisted Treatment Addiction Medicine Asheville March 21,2014 Melinda Campopiano, MD Medical Officer Substance Abuse & Mental Health Services Administration Guten Appetit
More informationMedical Malpractice Treatment Alprazolam benzodiazepine - A Case Study
Improving Outcomes in Patients Who are Prescribed Alprazolam with Concurrent Use of Opioids Pik-Sai Yung, M.D. Staff Psychiatrist Center for Counseling at Walton Background and Rationale Alprazolam is
More informationRULES AND REGULATIONS PERTAINING TO OPIOID OVERDOSE REPORTING
RULES AND REGULATIONS PERTAINING TO OPIOID OVERDOSE REPORTING [R23-1-OPOIDR] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH April 2014 (E) COMPILER S NOTES: Proposed Additions: The
More informationDrug Diversion. Controlled Substance Prescribing and Diversion
Drug Diversion Provider Presentation Controlled Substance Prescribing and Diversion Angela Wallace, R.Ph. Coastal District Inspector, PMP Law Enforcement Officer DHEC Bureau of Drug Control Presentation
More informationTestimony on Opioid Overdose Prevention. Daniel Raymond, Policy Director, Harm Reduction Coalition
Testimony on Opioid Overdose Prevention Daniel Raymond, Policy Director, Harm Reduction Coalition Presented on March 25, 2014 to the House Appropriations Subcommittee on Labor, Health and Human Services,
More informationStrengthening the HCV Continuum of Care
Strengthening the HCV Continuum of Care Fabienne Laraque, MD, MPH, Medical Director Viral Hepatitis Surveillance, Prevention and Control Bureau of Communicable Diseases Control, NYC DOHMH March 18, 2014
More informationCenter for Lawful Access and Abuse Deterrence 9/8/2014
ASPMN 24 th National Conference San Diego, CA September 17 20, 2014 Addressing an Evolving Epidemic Through Substance Use Intervention and Treatment Policies Michael C. Barnes Executive Director Conflict
More informationU.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health
TESTIMONY of the American Medical Association before the U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health Re: Examining Legislative Proposals to Combat our Nation's
More informationPatterns of Heroin and Other Substance Use in Youth and Young Adults in Suburban Cook County
Patterns of Heroin and Other Substance Use in Youth and Young Adults in Suburban Cook County 2014 School Nurse Conference Steven M. Seweryn, EdD, MPH April 24, 2014 Learning Objectives To become familiar
More informationPrescription Drug Monitoring Programs: Evaluation of Effectiveness
Prescription Drug Monitoring Programs: Evaluation of Effectiveness Eric Lavonas, MD Associate Director, Rocky Mountain Poison and Drug Center Denver Health and Hospital Authority Associate Professor, Department
More informationS. 524 AN ACT. To authorize the Attorney General to award grants to address the national epidemics of prescription opioid abuse and heroin use.
TH CONGRESS D SESSION S. AN ACT To authorize the Attorney General to award grants to address the national epidemics of prescription opioid abuse and heroin use. 1 Be it enacted by the Senate and House
More informationUTAH DRUG CONTROL UPDATE. Substance Abuse Treatment Admissions Data
UTAH DRUG CONTROL UPDATE This report reflects significant trends, data, and major issues relating to drugs in the State of Utah. Utah At-a-Glance: Approximately 6 percent of Utah residents reported past-month
More informationThe Supply Chain of Controlled Substances - Wholesale Drug Diversion - The Problem and DEA s New Strategy
Global Clinical Risk Management & Regulatory Policy Courtyard Alexandria Pentagon South Alexandria, VA 22304 July 11-12, 2013 The Supply Chain of Controlled Substances - Wholesale Drug Diversion - The
More informationWEST VIRGINIA DRUG CONTROL UPDATE. Drug Use Trends in West Virginia
WEST VIRGINIA DRUG CONTROL UPDATE This report reflects significant trends, data, and major issues relating to drugs in the State of West Virginia. West Virginia At-a-Glance: In 2007-2008, West Virginia
More informationNurse Practitioners' Role in Preparing Community Members for Opioid-Associated Overdose Rescue:
Nurse Practitioners' Role in Preparing Community Members for Opioid-Associated Overdose Rescue: Using a Computer-Based Module to Train Laypersons and Advocating for Naloxone Legislation International Nurses
More informationEMERGENCY DEPARTMENT VISITS INVOLVING NARCOTIC PAIN RELIEVERS
Relievers Pain Narcotic Involving Visits Department Emergency Drug Abuse Warning Network Short Report November 05, 2015 EMERGENCY DEPARTMENT VISITS INVOLVING NARCOTIC PAIN RELIEVERS AUTHORS Elizabeth H.
More informationSummit Spotlight Treatment Track breakout sessions announced
Volume 5, Issue 15, December 21, 2015 In This Issue: * Treatment Track breakout sessions announced 1. Drug overdose deaths reach all- time high 2. CDC releases draft opioid guidelines; seeks comments 3.
More informationWhat is an opioid? Why address opioid use in your county? Support the Prevention Agenda by Preventing Non-Medical Prescription Opioid Use and Overdose
Support the Prevention Agenda by Preventing Non-Medical Prescription Opioid Use and Overdose What is an opioid? Opioids are a type of pain-relief medication. According to the National Institute on Drug
More informationHow To Understand The Ppa
MTION OF STATE PREPTION NITONG PROGRAM PS This project was supported by Cooperative Agreement No. 202-DC-BX-K002 awarded by the Bureau of Justice Assistance. The Bureau of Justice Assistance is a component
More informationD R A F T SUMMARY. prescription monitoring information submitted under ORS 431A.860 to
LC 0 Regular Session // (SCT/ps) D R A F T SUMMARY Requires Oregon Health Authority to disclose prescription monitoring information to practitioner or pharmacist or member of practitioner s or pharmacist
More informationMandating PDMP participation by medical providers: current status and experience in selected states
Prescription Drug Monitoring Program Center of Excellence at Brandeis COE Briefing Mandating PDMP participation by medical providers: current status and experience in selected states Revision 1, February
More informationGovernor s Roundtable on Substance Abuse August 9, 2013 200 Chesapeake Blvd., Elkton MD
Governor s Roundtable on Substance Abuse August 9, 2013 200 Chesapeake Blvd., Elkton MD Stephanie Garrity, Cecil County Health Officer, welcomed those in attendance, announced that the Governor was running
More informationP U B L I C H E A L T H A D V I S O R Y
The Commonwealth of Massachusetts Executive Office of Health and Human Services Department of Public Health 250 Washington Street, Boston, MA 02108-4619Tel: 617-624-6000 Fax: 617-624-5206 www.mass.gov/dph
More informationFederal Response to Opioid Abuse Epidemic
Healthcare Committee Federal Response to Opioid Abuse Epidemic On May 1, 20215 the Energy and Commerce Subcommittee on Oversight and Investigations held a hearing entitled What is the Federal Government
More information